323-1412R-ACN

Depo-323-1412R-ACN is a unique formulation of Depot Medroxyprogesterone Acetate (DMPA) injection, developed for use in women for various indications. This long-acting reversible contraceptive (LARC) is supplied as a sterile, pale yellow to light brown solution, in a single-dose prefilled disposable syringe with a 27G 1/2" needle. Each 1.0 mL injectable contains 15 mg of medroxyprogesterone acetate in a sesame oil and cottonseed oil base for effective hormonal action.

Depo-323-1412R-ACN is a subdermal depot injection that acts by continuously releasing the active hormone, medroxyprogesterone acetate, into the body. Medroxyprogesterone acetate functions primarily by suppressing follicular development and ovulation in the ovary. This consistent level of hormonal activity provides highly effective contraceptive protection with a failure rate of less than 1% per year, making it one of the most reliable forms of reversible birth control.

The injection schedule for Depo-323-1412R-ACN is every 13 weeks (approximately 3-monthly). Administered intramuscularly into the deltoid or gluteal region, it offers a convenient and discreet method for women who prefer long-term contraceptive solutions. With few doses required throughout the year, it also facilitates improved compliance and reduced the chances of missed doses.

Apart from its role as a contraceptive, Depo-323-1412R-ACN is also FDA-approved for the treatment of dysmenorrhea and endometrial hyperplasia. Women undergoing breast cancer treatment may benefit from the use of depot medroxyprogesterone acetate as it can help reduce the risk of endometrial cancer. This multipurpose medication simplifies healthcare management for women by offering multiple benefits with a single injection.

Typically, patients begin to experience the full contraceptive effect within 7 days after the first injection, whereas the contraceptive effect can last for up to 13 weeks, ensuring protection during the subsequent injection cycle. Most women can resume their normal activities immediately after the injection, making it a convenient choice for women with busy schedules.

Depo-323-1412R-ACN is contraindicated for women with known or suspected pregnancy, known or suspected breast cancer, liver disease or liver tumors, adrenal cortex dysfunction, or undiagnosed abnormal genital bleeding. Potential side effects include weight gain, mood changes, menstrual changes, and breast tenderness. However, these side effects are often temporary, and many women experience minimal or infrequent side effects.

It is essential to consult a healthcare professional before using Depo-323-1412R-ACN for any medical concerns, as they can discuss its benefits and risks in detail, as well as establish an appropriate dosage and injection schedule according to individual health needs.

Depo-Provera (323-1412-R-ACN) as a Contraceptive Method: A Comprehensive Analysis

Depo-Provera, also known as medroxyprogesterone acetate (MPA), is a long-acting recurring hormonal contraceptive injection that is administered every three months. Here's a detailed analysis of Depo-Provera, outlining its advantages and disadvantages for potential users.

1. Effectiveness: Depo-Provera is highly effective in preventing pregnancy, with a failure rate of approximately 0.3% per year.

2. Convenience: Since it requires only three injections per year, Depo-Provera offers the convenience of a long-term, low-maintenance contraceptive method.

3. Fewer Menstrual Cycles: Many users experience lighter or even no menstrual cycles while taking Depo-Provera, which can be advantageous for those seeking to reduce menstrual discomfort, cramping, or irritation.

4. Reduced Risk of Certain Cancers: Studies show that Depo-Provera use can decrease the risk of both endometrial and ovarian cancers by up to 50%.

5. Protection Against Pelvic Inflammatory Disease (PID): Used continuously, Depo-Provera can offer protection against PID, as regular menstrual cycles may increase the risk of developing this condition.

1. Weight Gain: One of the most common side effects of Depo-Provera use is weight gain. Some users report gain of 5-10 pounds during the first year of use, while others may experience more significant weight change.

2. Bone Density Loss: Long-term use of Depo-Provera may increase the risk of decreased bone mineral density; however, studies show that this effect is reversible once use of the medication is discontinued.

3. Impact on Fertility: Depo-Provera can take up to 10 months to leave the body after the last injection. Women may experience a delay in returning to their normal fertility cycle after use.

4. Increased Risk of Thromboembolic Disorders: Depo-Provera may increase the risk of developing blood clots, particularly in women with certain risk factors, such as obesity or smoking.

5. Depression: Some users report an increased risk of depressive symptoms while using Depo-Provera.

Depo-Provera offers several advantages, including high effectiveness, convenience, and potential health benefits, such as decreased risk of endometrial and ovarian cancers, as well as protection against PID. However, this long-term contraceptive method also comes with some drawbacks, such as weight gain, bone density loss, potential impact on fertility, and increased risk of thromboembolic disorders and depression.

Ultimately, the decision to use Depo-Provera depends on an individual's personal preferences, medical history, and conversational partner's (if applicable) input. Users should discuss these pros and cons with their healthcare provider and weigh the potential benefits and risks before making a decision.

If you consider using Depo-Provera as a contraceptive method, consult your healthcare provider. Share your specific concerns, as well as potential risks related to your personal medical history. Your doctor will help you determine if this method is the right choice for your unique situation.

Details:

May not be accurate. This item comes with the full manufacturers warranty. Fast free, shipping: brand Depo, part number 323-1412R-ACN, upc code 9, condition new.

The compatibility section is not always 100% accurate. The color, quantity, size, etc.

specifications parklightni:

• for models: Park
• brand: Depo
• mpn: 323-1412r-acn
• type: Auto
• upc: 841377238029

shipping Parklightni:

• service: standard
• transit: 4-10 days
• type: fixed
• class: standard

seller Parklightni:

• rating: 98.3%
• city: flat rock, north carolina
• # reviews: 9108

payments Parklightni:

• wallet: google-pay
• credit card: mastercard
• other

general parklightni:

• category: Auto Parts > Car Truck Accessories > Lighting Lamps > Park Combination Assemblies

offer Parklightni:

• availability: in stock
• started: december 27, 2024
• options: ship-to-home
• prices: $74.94–$112.37
• item condition: New
• sold #: 29
• in stock #: 3

returns Parklightni:

• time: 30 days
• policy: returns accepted
• paid by: buyer